These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
569 related articles for article (PubMed ID: 29746588)
1. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma. Chen D; Luo L; Liang C PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588 [TBL] [Abstract][Full Text] [Related]
2. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. Xu XL; Gong Y; Zhao DP Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913 [TBL] [Abstract][Full Text] [Related]
3. USP4 expression independently predicts favorable survival in lung adenocarcinoma. Zhong M; Jiang Q; Jin R IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299 [TBL] [Abstract][Full Text] [Related]
4. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma. Liu X; Chen L; Zhang T Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091 [TBL] [Abstract][Full Text] [Related]
6. Hou L; Li Y; Wang Y; Xu D; Cui H; Xu X; Cong Y; Yu C Dis Markers; 2018; 2018():4108919. PubMed ID: 30420903 [TBL] [Abstract][Full Text] [Related]
7. Zhang W; Li T; Hu B; Li H Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541 [TBL] [Abstract][Full Text] [Related]
8. High Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629 [TBL] [Abstract][Full Text] [Related]
9. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma. Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286 [TBL] [Abstract][Full Text] [Related]
10. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma. Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462 [TBL] [Abstract][Full Text] [Related]
11. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival. Chen J; Chen H; Yang H; Dai H Biomed Pharmacother; 2018 Apr; 100():233-239. PubMed ID: 29432994 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma. Kobayashi M; Nagashio R; Saito K; Aguilar-Bonavides C; Ryuge S; Katono K; Igawa S; Tsuchiya B; Jiang SX; Ichinoe M; Murakumo Y; Saegusa M; Satoh Y; Sato Y Hum Pathol; 2018 Apr; 74():148-155. PubMed ID: 29320753 [TBL] [Abstract][Full Text] [Related]
13. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma. Yu C; Hou L; Cui H; Zhang L; Tan X; Leng X; Li Y Future Oncol; 2018 Oct; 14(24):2483-2492. PubMed ID: 29756998 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
15. STK24 expression is modulated by DNA copy number/methylation in lung adenocarcinoma and predicts poor survival. Huang N; Lin W; Shi X; Tao T Future Oncol; 2018 Sep; 14(22):2253-2263. PubMed ID: 29557182 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma. Zhang JT; Lin YC; Xiao BF; Yu BT Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma. Guo CY; Zhu Q; Tou FF; Wen XM; Kuang YK; Hu H BMC Cancer; 2019 Mar; 19(1):289. PubMed ID: 30925904 [TBL] [Abstract][Full Text] [Related]
18. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma. Wang H; Wei C; Pan P; Yuan F; Cheng J Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305 [TBL] [Abstract][Full Text] [Related]
19. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies. Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089 [TBL] [Abstract][Full Text] [Related]
20. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma. Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]